Ionis Pharmaceuticals ($IONS)

Description

Develops RNA- and DNA-targeted medicines for people with serious diseases, with marketed therapies including TEGSEDI and WAYLIVRA for specific rare disease indications.

Related

• Krystal Biotech ($KRYS)Develops and delivers redosable genetic medicines, including VYJUVEK for dystrophic epidermolysis bullosa, using engineered HSV-1 vectors…
• Liquidia ($LQDA)Develops therapies and lung drug-delivery technology for rare cardiopulmonary diseases, including pulmonary arterial hypertension,…
• Vertex Pharmaceuticals ($VRTX)Discovers, develops, and produces medicines for people with serious diseases, while offering treatment support and information about…
• BMS Cell Therapy Washington ($BMY)Develops, manufactures, and commercializes cancer immunology and cell therapies for people with difficult-to-treat cancers and other…
• Vertex Pharmaceuticals (San Diego)Discovers, develops, and produces medicines for serious diseases, while providing medical information, patient support, and clinical trial…
• Moderna ($MRNA)Develops mRNA medicines using a platform for designing, researching, and testing mRNA, with a focus on addressing infectious and serious…
• Poseida Therapeutics (Roche)Develops cell therapy candidates and related platform technologies, with legacy programs in a biotechnology pipeline for medicines…
• Beam Therapeutics ($BEAM)Develops investigational base-editing genetic medicines and delivery technologies, including electroporation, nonviral, and viral methods,…
• Editas Medicine ($EDIT)Develops CRISPR-based gene editing medicines, including in vivo approaches, for people with serious diseases where modifying genes may…
• BioCryst Pharmaceuticals ($BCRX)Develops oral small-molecule and injectable protein medicines for hereditary angioedema and other rare diseases, with physician-requested…
• Xaira TherapeuticsBuilds an AI-powered drug discovery and development platform to decode disease, design therapies, and support end-to-end medicine creation…
• Lilly Institute for Genetic MedicineRNA, DNA, and genetic-medicine research hub translating Lilly's biologics platform into next-generation therapies. Boston MA site.